Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Goodwill (2016 - 2026)

Avanos Medical's Goodwill history spans 13 years, with the latest figure at $394.9 million for Q4 2025.

  • On a quarterly basis, Goodwill fell 13.32% to $394.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $394.9 million, a 13.32% decrease, with the full-year FY2025 number at $394.9 million, down 13.32% from a year prior.
  • Goodwill hit $394.9 million in Q4 2025 for Avanos Medical, roughly flat from $394.4 million in the prior quarter.
  • Over the last five years, Goodwill for AVNS hit a ceiling of $826.0 million in Q1 2022 and a floor of $381.2 million in Q2 2025.
  • Historically, Goodwill has averaged $701.1 million across 5 years, with a median of $794.6 million in 2024.
  • Biggest five-year swings in Goodwill: increased 4.71% in 2023 and later plummeted 52.01% in 2025.
  • Tracing AVNS's Goodwill over 5 years: stood at $742.5 million in 2021, then rose by 2.4% to $760.3 million in 2022, then increased by 4.71% to $796.1 million in 2023, then tumbled by 42.77% to $455.6 million in 2024, then dropped by 13.32% to $394.9 million in 2025.
  • Business Quant data shows Goodwill for AVNS at $394.9 million in Q4 2025, $394.4 million in Q3 2025, and $381.2 million in Q2 2025.